Vaccine panel’s hepatitis B vote signals further turbulence for immunization policy, public trust

On Dec. 5, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to end the universal U.S. recommendation for the newborn dose of the hepatitis B vaccine, instead adopting a policy urging individual-based decision-making.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup